Send feedback

MAP2K2 p.Arg185Gln

c.554G>A · rs772139417 · VCV1389303

Uncertain significance Multiple submitters
Classification
Uncertain significance
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 2 submitters
AlphaMissense
likely pathogenic
0.8923 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.00181%, amr)
Missense predictors
2/2 damaging
AlphaMissense, SaProt · REVEL indeterminate
Conditions
1
RASopathy

Computational evidence

Protein change
AlphaMissense0.8923likely pathogenic
REVEL0.367indeterminate
SaProtLLR -10.50damaging
⇒ AlphaMissense and SaProt both call this damaging; REVEL is indeterminate.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 7.6GERP 0.57, phastCons 1
Regional constrainto/e 0.67unconstrained · MANE · 18 kb · p 1.4e-08 · regional, not allelic
Overall
CADD26.4PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean damaging — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00181% Admixed American · 1/55,312 alleles
Filtering AF 0.000772% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.000612%
Overall 0.00107% 17/1,585,544 alleles · very rare exomes 13/1,433,552 · genomes 4/151,992 · joint denominator
Ancestry group Frequency 1 in
Ashkenazi Jewishnot grpmax-eligible 0.00345% 28,948
Admixed Americangrpmax 0.00181% 55,312
European (non-Finnish) 0.00129% 77,791

Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
MAP2K2
Protein
p.Arg185Gln
Coding
c.554G>A
MANE Select
NM_030662
dbSNP
rs772139417
Type
single nucleotide variant
Location
chr19:4101255 (GRCh38)
Gene constraint
LOEUF 0.858 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 82.54 · 3 PDB
Residue 185
the protein kinase domain; an α-helix
Full MAP2K2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/map2k2-p-arg185gln (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown